Stay updated on MOST: Stroke Thrombolysis Clinical Trial
Sign up to get notified when there's something new on the MOST: Stroke Thrombolysis Clinical Trial page.

Latest updates to the MOST: Stroke Thrombolysis Clinical Trial page
- Check2 days agoChange DetectedAdded a new prespecified subgroup analysis publication from the MOST Trial (thrombolysis alone vs with Argatroban/Eptifibatide) with full citation and author list. No deletions detected.SummaryDifference2%
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedRelease v3.2.0 includes a critical government-funding status notice and links for operating status, replacing the previous v3.1.0.SummaryDifference3%
- Check24 days agoChange DetectedUpdated to Revision v3.1.0 and removal of multiple drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs), indicating content pruning in the drug-safety area and a new version tag.SummaryDifference0.3%
- Check31 days agoChange DetectedMinor bibliographic formatting changes to a cited article; essentially no substantive content change.SummaryDifference0.0%
- Check38 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the old revision label was removed. The 'Back to Top' element was also removed, which is a minor UI change.SummaryDifference0.2%
- Check45 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%
Stay in the know with updates to MOST: Stroke Thrombolysis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MOST: Stroke Thrombolysis Clinical Trial page.